Template:DrugProjectFormSinglePage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 131: | Line 131: | ||
====Non–Guideline-Supported Use==== | ====Non–Guideline-Supported Use==== | ||
{{{offLabelAdultNoGuideSupport}}} | {{{offLabelAdultNoGuideSupport|}}} | ||
}} | }} | ||
| Line 139: | Line 139: | ||
===FDA-Labeled Indications and Dosage (Pediatric)=== | ===FDA-Labeled Indications and Dosage (Pediatric)=== | ||
{{{fdaLIADPed}}} | {{{fdaLIADPed|}}} | ||
}} | }} | ||
| Line 147: | Line 147: | ||
====Guideline-Supported Use==== | ====Guideline-Supported Use==== | ||
{{{offLabelPedGuideSupport}}} | {{{offLabelPedGuideSupport|}}} | ||
}} | }} | ||
{{#if: {{{offLabelPedNoGuideSupport|}}} | | {{#if: {{{offLabelPedNoGuideSupport|}}} | | ||
====Non–Guideline-Supported Use==== | ====Non–Guideline-Supported Use==== | ||
{{{offLabelPedNoGuideSupport}}} | {{{offLabelPedNoGuideSupport|}}} | ||
}} | }} | ||
==Contraindications== | ==Contraindications== | ||
{{{contraindications}}} | {{{contraindications|}}} | ||
==Warnings== | ==Warnings== | ||
| Line 164: | Line 164: | ||
}} | }} | ||
{{{warnings}}} | {{{warnings|}}} | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
| Line 170: | Line 170: | ||
===Clinical Trials Experience=== | ===Clinical Trials Experience=== | ||
{{{clinicalTrials}}} | {{{clinicalTrials|}}} | ||
===Postmarketing Experience=== | ===Postmarketing Experience=== | ||
{{{postmarketing}}} | {{{postmarketing|}}} | ||
==Drug Interactions== | ==Drug Interactions== | ||
{{{drugInteractions}}} | {{{drugInteractions|}}} | ||
==Use in Specific Populations== | ==Use in Specific Populations== | ||
| Line 188: | Line 188: | ||
{{#if: {{{useInPregnancyFDA|}}} | | {{#if: {{{useInPregnancyFDA|}}} | | ||
{{{useInPregnancyFDA}}} | | {{{useInPregnancyFDA|}}} | | ||
There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} | ||
| Line 195: | Line 195: | ||
{{#if: {{{useInPregnancyAUS|}}} | | {{#if: {{{useInPregnancyAUS|}}} | | ||
{{{useInPregnancyAUS}}} | | {{{useInPregnancyAUS|}}} | | ||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} | ||
| Line 202: | Line 202: | ||
{{#if: {{{useInLaborDelivery|}}} | | {{#if: {{{useInLaborDelivery|}}} | | ||
{{{useInLaborDelivery}}} | | {{{useInLaborDelivery|}}} | | ||
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | ||
}} | }} | ||
| Line 209: | Line 209: | ||
{{#if: {{{useInNursing|}}} | | {{#if: {{{useInNursing|}}} | | ||
{{{useInNursing}}} | | {{{useInNursing|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in women who are nursing. | There is no FDA guidance on the use of {{PAGENAME}} in women who are nursing. | ||
}} | }} | ||
| Line 216: | Line 216: | ||
{{#if: {{{useInPed|}}} | | {{#if: {{{useInPed|}}} | | ||
{{{useInPed}}} | | {{{useInPed|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in pediatric settings. | There is no FDA guidance on the use of {{PAGENAME}} in pediatric settings. | ||
}} | }} | ||
| Line 223: | Line 223: | ||
{{#if: {{{useInGeri|}}} | | {{#if: {{{useInGeri|}}} | | ||
{{{useInGeri}}} | | {{{useInGeri|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in geriatric settings. | There is no FDA guidance on the use of {{PAGENAME}} in geriatric settings. | ||
}} | }} | ||
| Line 230: | Line 230: | ||
{{#if: {{{useInGender|}}} | | {{#if: {{{useInGender|}}} | | ||
{{{useInGender}}} | | {{{useInGender|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations. | There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations. | ||
}} | }} | ||
| Line 237: | Line 237: | ||
{{#if: {{{useInRace|}}} | | {{#if: {{{useInRace|}}} | | ||
{{{useInRace}}} | | {{{useInRace|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations. | There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations. | ||
}} | }} | ||
| Line 244: | Line 244: | ||
{{#if: {{{useInRenalImpair|}}} | | {{#if: {{{useInRenalImpair|}}} | | ||
{{{useInRenalImpair}}} | | {{{useInRenalImpair|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment. | There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment. | ||
}} | }} | ||
| Line 251: | Line 251: | ||
{{#if: {{{useInHepaticImpair|}}} | | {{#if: {{{useInHepaticImpair|}}} | | ||
{{{useInHepaticImpair}}} | | {{{useInHepaticImpair|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment. | There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment. | ||
}} | }} | ||
| Line 258: | Line 258: | ||
{{#if: {{{useInReproPotential|}}} | | {{#if: {{{useInReproPotential|}}} | | ||
{{{useInReproPotential}}} | | {{{useInReproPotential|}}} | | ||
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males. | There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males. | ||
}} | }} | ||
| Line 265: | Line 265: | ||
{{#if: {{{useInImmunocomp|}}} | | {{#if: {{{useInImmunocomp|}}} | | ||
{{{useInImmunocomp}}} | | {{{useInImmunocomp|}}} | | ||
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised. | There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised. | ||
}} | }} | ||
{{#if: {{{othersTitle|}}}| | {{#if: {{{othersTitle|}}}| | ||
===={{{othersTitle}}}==== | ===={{{othersTitle|}}}==== | ||
{{{useInOthers}}} | {{{useInOthers|}}} | ||
}} | }} | ||
| Line 278: | Line 278: | ||
====Administration==== | ====Administration==== | ||
{{{administration}}} | {{{administration|}}} | ||
====Monitoring==== | ====Monitoring==== | ||
{{{monitoring}}} | {{{monitoring|}}} | ||
==IV compatibility== | ==IV compatibility== | ||
{{#if: {{{IVCompat|}}} | | {{#if: {{{IVCompat|}}} | | ||
{{{IVCompat}}} | | {{{IVCompat|}}} | | ||
There is limited information about the compatibility of {{PAGENAME}} and IV administrations. | There is limited information about the compatibility of {{PAGENAME}} and IV administrations. | ||
}} | }} | ||
| Line 293: | Line 293: | ||
==Overdosage== | ==Overdosage== | ||
{{#if: {{{overdose|}}} | | {{#if: {{{overdose|}}} | | ||
{{{overdose}}} | | {{{overdose|}}} | | ||
There is limited information about {{PAGENAME}} overdose. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately. | There is limited information about {{PAGENAME}} overdose. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately. | ||
}} | }} | ||
==Pharmacology== | ==Pharmacology== | ||
{{drugBox}} | {{drugBox|}} | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
{{{mechAction}}} | {{{mechAction|}}} | ||
===Structure=== | ===Structure=== | ||
{{{structure}}} | {{{structure|}}} | ||
===Pharmacodynamics=== | ===Pharmacodynamics=== | ||
{{{PD}}} | {{{PD|}}} | ||
===Pharmacokinetics=== | ===Pharmacokinetics=== | ||
{{{PK}}} | {{{PK|}}} | ||
===Nonclinical Toxicology=== | ===Nonclinical Toxicology=== | ||
{{{nonClinToxic}}} | {{{nonClinToxic|}}} | ||
==Clinical Studies== | ==Clinical Studies== | ||
{{{clinicalStudies}}} | {{{clinicalStudies|}}} | ||
==How Supplied== | ==How Supplied== | ||
{{{howSupplied}}} | {{{howSupplied|}}} | ||
* {{{NDC}}}: | * {{{NDC|}}}: | ||
* {{{storage}}}: | * {{{storage|}}}: | ||
* {{{manBy}}}: | * {{{manBy|}}}: | ||
* {{{distBy}}}: | * {{{distBy|}}}: | ||
==Images== | ==Images== | ||
{{{imageFreeText}}} | {{{imageFreeText|}}} | ||
===Drug Images=== | ===Drug Images=== | ||
{{{drugImages}}} | {{{drugImages|}}} | ||
===Package and Label Display Panel=== | ===Package and Label Display Panel=== | ||
{{{packLabel}}} | {{{packLabel|}}} | ||
==Patient Information== | ==Patient Information== | ||
===Patient Information from FDA=== | ===Patient Information from FDA=== | ||
{{{fdaPatientInfo}}} | {{{fdaPatientInfo|}}} | ||
===Patient Information from NLM=== | ===Patient Information from NLM=== | ||
{{{nlmPatientInfo}}} | {{{nlmPatientInfo|}}} | ||
==Precautions with Alcohol== | ==Precautions with Alcohol== | ||
{{#if: {{{alcohol|}}} | | {{#if: {{{alcohol|}}} | | ||
{{{alcohol}}} | | {{{alcohol|}}} | | ||
Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. | Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. | ||
}} | }} | ||
| Line 358: | Line 358: | ||
==Look-Alike Drug Names== | ==Look-Alike Drug Names== | ||
{{{ | {{{|lookAlike|}}} | ||
}} | }} | ||
==[http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050792.htm Drug Shortage Status]== | ==[http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050792.htm Drug Shortage Status]== | ||
{{{drugShortage}}} | {{{drugShortage|}}} | ||
==Price== | ==Price== | ||
Revision as of 16:27, 3 April 2014
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm
|authorTag=
|genericName=
|drugClass=
|indication=
|commonAdverseReactions=
|isPill=
|imageFreeText=
|pillImprint=
|dosageValue=
|dosageUnit=
|dosageFreeText=
|pillSize=
|pillShape=
|pillColor=
|pillScoring=
|pillImage=
|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdultGuideSupport=
|offLabelAdultNoGuideSupport=
|fdaLIADPed=
|offLabelPedGuideSupport=
|offLabelPedNoGuideSupport=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|FDAPregCat=
|useInPregnancyFDA=
|AUSPregCat=
|useInPregnancyAUS=
|useInLaborDelivery=
|useInNursing=
|useInPed=
|useInGeri=
|useInGender=
|useInRace=
|useInRenalImpair=
|useInHepaticImpair=
|useInReproPotential=
|useInImmunocomp=
|othersTitle=
|useInOthers=
|administration=
|monitoring=
|IVCompat=
|overdose=
|drugBox=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|NDC=
|storage=
|manBy=
|distBy=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|alcohol=
|lookAlike=
|drugShortage=
|price=
}}
Edit the page to see the template text.